Michael C. Campbell, MD

Case Report

Recurrent Use of Implantable Buprenorphine

December 5, 2019

The FDA has approved buprenorphine implants for 1 year of total use or 2 sets of implants. This case demonstrates successful use of implantable buprenorphine past 1 year.

Letter to the Editor

Hyponatremia and Central Pontine Myelinolysis as a Result of Beer Potomania: A Case Report

August 26, 2010